시간 | 제목 | 발표자 | 파일 |
---|---|---|---|
09:00 ~ 10:00 | Management of Lymph Node-Positive Penile Cancer | In Ho CHANG | |
09:00 ~ 10:00 | Contemporary Retroperitoneal Lymph Node Dissection for Testis Cancer | Myungsun SHIM | |
09:00 ~ 10:00 | Tamsulosin 0.4mg use in Asian Patients | U-Syn HA | |
선택:00 | Panel Discussion | Stephen J. FREEDLAND , Lukman HAKIM , Tae Young JUNG , Peter F.A. MULDERS , Jung Sik HUH , Giuseppe PROCOPIO , Seung Chol PARK , Bannakij LOJANAPIWAT |
시간 | 제목 | 발표자 | 파일 |
---|---|---|---|
10:20 ~ 11:40 | NMIBC BCG Unresponsive Disease | Seth P. LERNE | |
10:20 ~ 11:40 | Urine Markers for Bladder Cancer | Seok Joong YUN | |
10:20 ~ 11:40 | Enhanced Technique Endoscopic Visualization in NMIBC | Seok Ho KANG | |
10:20 ~ 11:40 | Role of IO in NMIBC | Ho Kyung SEO | |
10:20 ~ 11:40 | Panel Discussion | Giuseppe PROCOPIO , Rainy UMBAS , Young-Sig KIM , Peter F.A. MULDERS , Bannakij LOJANAPIWAT , Shigeo HORIE , Jeong Kyun YEO |
시간 | 제목 | 발표자 | 파일 |
---|---|---|---|
12:40 ~ 14:15 | Focal Therapy Eligibility Determined by mpMRI or mpMRI/US Fusion Biopsy | Hwang Gyun JEON | |
12:40 ~ 14:15 | Molecular Imaging in the Management of Prostate Cancer | Robert E. REITER | |
12:40 ~ 14:15 | How to Manage Node-Positive Prostate Cancer | Hong Koo HA | |
12:40 ~ 14:15 | Practical Guidance on the Comorbidity in the Treatment of mCRPC | Jae Young JOUNG | |
12:40 ~ 14:15 | RANKL Inhibition as a Treatment Option in Preventing Skeletal-Related Events (SRE) in Patients with Bone Metastases in Prostate Cancer | Won Sik JANG | |
12:40 ~ 14:15 | Panel Discussion | Hideyuki AKAZA , Taek Won KANG , Giuseppe PROCOPIO , Seth Paul LERNER , Kyo Chul KOO , Jacob See-Tong PANG , Sung-Woo PARK , Teng Aik ONG , Jin Seon CHO |
시간 | 제목 | 발표자 | 파일 |
---|---|---|---|
14:35 ~ 15:55 | Optimization of Imaging in Renal Tumors: Use of CAIX Antibody | Peter F.A. MULDERS | |
14:35 ~ 15:55 | The Role of Arterial Embolization in RCCa | Hyun Tae KIM | |
14:35 ~ 15:55 | Incidence of Benign Lesions among Small Renal Masses Treated with Surgery: Impact of Diagnostic Tests for Characterization | In Gab JEONG | |
14:35 ~ 15:55 | Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program | Giuseppe PROCOPIO | |
14:35 ~ 15:55 | Panel Discussion | Cheryn SONG , Lukman HAKIM , Sung-Hoo HONG , Robert E. REITER , Jun Sung KOH (Korea), Bannakij LOJANAPIWAT , Jae Sung LIM , Stephen J. FREEDLAND |
시간 | 제목 | 발표자 | 파일 |
---|---|---|---|
15:55 ~ 17:15 | Neoadjuvant Treatment Prior to Prostatectomy in High-Risk Disease | Dalsan YOU | |
15:55 ~ 17:15 | Local Treatment in Patients with Newly Diagnosed Metastatic Disease: Myth or Reality? | Se Yun KWON | |
15:55 ~ 17:15 | Current Management of Hormone Sensitive Prostate Cancer | Seung Hwan LEE | |
15:55 ~ 17:15 | CRPC: Definition and Treatment Options | Stephen J. FREEDLAND | |
15:55 ~ 17:15 | Panel Discussion | Shigeo HORIE , Seth Paul LERNER , Jeong Seok HWA , Hideyuki AKAZA , Sun Il KIM , Lukman HAKIM , Soo Dong KIM , Rainy UMBAS , Young Hwii KO , Sang Eun LEE |